Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy

Journal of Clinical Oncology

Volumn 29, Issue 20, 2011, Pages

  Rubenstein, James L ^a   Treseler, Patrick A ^a   Stewart, Paul J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE PLUS RITUXIMAB; CYTARABINE; DOXORUBICIN; LENALIDOMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; DRUG MEGADOSE; FEMALE; GAMMA KNIFE RADIOSURGERY; HUMAN; HUMAN TISSUE; INTRAOCULAR TUMOR; LARGE CELL LYMPHOMA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VITRECTOMY;

ANTINEOPLASTIC AGENTS; EYE NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; THALIDOMIDE;

EID: 79960203917     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.34.7252     Document Type: Article

References (17)

1. Berenbom A, Davila RM, Lin HS, et al: Treatment outcomes for primary intraocular lymphoma: Implications for external beam radiotherapy. Eye (Lond) 21:1198-1201, 2007 (Pubitemid 47382147)
2. Stefanovic A, Davis J, Murray T, et al: Treatment of isolated primary intraocular lymphoma with high-dose methotrexate-based chemotherapy and binocular radiation therapy: A single-institution experience. Br J Haematol 151: 103-106, 2010
3. Batchelor TT, Kolak G, Ciordia R, et al: High-dose methotrexate for intraocular lymphoma. Clin Cancer Res 9:711-715, 2003 (Pubitemid 36182604)
4. Jahnke K, Wagner T, Bechrakis NE, et al: Pharmacokinetics and efficacy of ifosfamide or trofosfamide in patients with intraocular lymphoma. Ann Oncol 16:1974-1978, 2005
5. Soussain C, Suzan F, Hoang-Xuan K, et al: Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19:742-749, 2001 (Pubitemid 32119089)
6. Itty S, Pulido JS: Rituximab for intraocular lymphoma. Retina 29:129-132, 2009
7. Pulido JS, Bakri SJ, Valyi-Nagy T, et al: Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. Retina 27:1071-1073, 2007 (Pubitemid 350304009)
8. Kitzmann AS, Pulido JS, Mohney BG, et al: Intraocular use of rituximab. Eye (Lond) 21:1524-1527, 2007
9. Frenkel S, Hendler K, Siegal T, et al: Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol 92:383-388, 2008 (Pubitemid 351363536)
10. Grimm SA, McCannel CA, Omuro AM, et al: Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology 71:1355-1360, 2008
11. Rubenstein JL, Fridlyand J, Abrey L, et al: Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J Clin Oncol 25:1350-1356, 2007 (Pubitemid 46706881)
12. Chanan-Khan AA, Cheson BD: Lenalidomide for the treatment of B-cell malignancies. J Clin Oncol 26:1544-1552, 2008
13. Davies F, Baz R: Lenalidomide mode of action: Linking bench and clinical findings. Blood Rev 24:S13-S19, 2010 (suppl 1)
14. Lu L, Payvandi F, Wu L, et al: The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions. Microvasc Res 77:78-86, 2009
15. Wiernik PH, Lossos IS, Tuscano JM, et al: Lenalidomide monotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma. J Clin Oncol 26: 4952-4957, 2008
16. Witzig TE, Wiernik PH, Moore T, et al: Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's lymphoma. J Clin Oncol 27:5404-5409, 2009
17. Witzig TE, Vose JM, Luigi Zinzani P, et al: An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma. Ann Oncol [epub ahead of print on January 12, 2011]